Key points are not available for this paper at this time.
Lung cancer LDCT screening is cost-effective in a high-risk population. The optimal screening scenario is dependent on sex.
Du et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: